Increasing Investment by Pharmaceutical Companies and Favorable Government Policies has Propelled the Growth of the Peptide Therapeutics Market in the North America Region!

• Himanshu Patni
• May 16, 2023
• HEALTHCARE, NEWS
• Peptide Therapeutics Market, Peptide Therapeutics Market Analysis, Peptide Therapeutics Market Forecast, Peptide Therapeutics Market Growth, Peptide Therapeutics Market Outlook, Peptide Therapeutics Market Share, Peptide Therapeutics Market Trends
• 0 Comments

The increased adoption of targeted peptide drugs, rising awareness regarding the availability of peptide therapeutics, and the rising biopharmaceutical industry is driving regional growth. According to the American Cancer Society, “Cancer and Figures 2022”, there was an estimated 1.9 million new cancer cases diagnosed in 2022. Moreover, as per the same source in 2020, the most common cancers were breast (253,465), lung (227,875), prostate (209,512), and colon (101,809) in the U.S. Thus, the increasing cases of cancer require early treatment which is expected to increase the demand for peptide therapeutics over the forecast period. Apart from this, the presence of major key players and rising investments by pharmaceutical companies are also propelling regional market growth.

Get the inside scoop with Sample report:-  https://univdatos.com/report/peptide-therapeutics-market/get-a-free-sample-form.php?product_id=37314

Further, the North America Peptide therapeutics market was valued at USD 25 billion in 2021 & is expected to grow at a CAGR of 9% from 2022-2030.  North America held a dominant share in the market in 2021 owing to the increased adoption of targeted therapy and rise in the incidence of cancer in U.S. According to the Globocan 2020 report, an estimated 2,281,658 new cancer cases were diagnosed in the U..S in 2020, with nearly 612,390 deaths. Apart from this, the presence of major key players, rising investments by pharmaceutical companies, and favorable government regulatory policies are also propelling the regional market growth. For instance, in July 2022, Peptilogics received U.S. FDA fast-track designation for PLG0206, for the treatment of periprosthetic joint infection (PJI).

 FIG. 1      North America Peptide Therapeutics Market Revenue (2020-2030)- USD Mn

For a detailed analysis of the Global Peptide Therapeutics Market browse through – https://univdatos.com/report/peptide-therapeutics-market/

Based on drug type, the market is bifurcated into branded and generic. The branded category held a significant share of the market in 2021 mainly due to the rising research and development investment by pharmaceutical companies, product launches, and high prescription rates.

By application, the market is segmented into cancer, metabolic, cardiovascular disorders, respiratory, hematological disorders, anti-infection, dermatology, CNS, and others. The cancer category is anticipated to grow with high CAGR during the forecast period owing to the high specificity and targetability of peptide therapeutics. Other factors, such as a surge in the prevalence of cancer, rapid product launches, and increasing research and development activities are also driving the segment growth. For instance, in June 2021, Nimble Therapeutics announced a collaboration with RayzeBio to discover and develop novel peptide-based radiopharmaceuticals for the treatment of cancer.

Global Peptide Therapeutics Market Segmentation

Market Insight, by Drug Type

·        Branded

·        Generic

Market Insights, by Route of Administration

·        Parental

·        Mucosal

·        Oral

·        Transdermal

Market Insights, by Application

·        Cancer

·        Metabolic

·        Cardiovascular Disorder

·        Respiratory

·        Haematological Disorders

·        Anti-infection

·        Dermatology

·        CNS

·        Others

Market Insights, by Distribution Channel

·        Hospital Pharmacies

·        Retail Pharmacies

·        Online Pharmacies

Market Insight, by Region

·        North America

o   U.S.

o   Canada

o   Rest of North America

·        Europe

o  Germany

o  U.K.

o  France

o  Spain

o  Italy

o  Rest of Europe

·        APAC

o  China

o  Japan

o  India

o  South Korea

o  Rest of APAC

·        Rest of the World

Top Company Profiles

·        AbbVie Inc.

·        Pfizer Inc.

·        Lilly

·        Amgen Inc.

·        Bristol-Myers Squibb Company

·        Takeda Pharmaceutical Company Limited

·        Sanofi

·        F. Hoffmann-La Roche Ltd

·        GSK plc

·        Novartis AG